Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KLKB1 | P03952 | 1/20 | 0.50 |
| ▸ | ELANE | P08246 | 4/20 | 0.49 |
| ▸ | NNMT | P40261 | 2/20 | 0.46 |
| ▸ | PLAU | P00749 | 1/20 | 0.46 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.44 |
| ▸ | ITGB3 | P05106 | 2/20 | 0.42 |
| ▸ | ITGB1 | P05556 | 2/20 | 0.42 |
| ▸ | ITGAV | P06756 | 2/20 | 0.42 |
| ▸ | ITGA5 | P08648 | 2/20 | 0.42 |
| ▸ | ITGB5 | P18084 | 1/20 | 0.42 |
| ▸ | MC4R | P32245 | 6/20 | 0.41 |
| ▸ | MC5R | P33032 | 6/20 | 0.41 |
| ▸ | MC3R | P41968 | 6/20 | 0.41 |
| ▸ | MC1R | Q01726 | 6/20 | 0.41 |
| ▸ | CTSG | P08311 | 1/20 | 0.41 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29388360 | 0.93 | ELANE (0.53) | KLKB1ELANENNMTPLAUCACNA1B | |
| SCHEMBL29388680 | 0.88 | PLAU (0.59) | ELANENNMTPLAUCACNA1BITGB3 | |
| SCHEMBL29387473 | 0.85 | ITGB3 (0.59) | KLKB1ELANENNMTPLAUCACNA1B | |
| SCHEMBL12518412 | 0.75 | ITGB3 (0.44) | KLKB1NNMTITGB3ITGAVITGB5 | |
| SCHEMBL15082201 | 0.74 | CACNA1B (0.56) | KLKB1ELANENNMTPLAUCACNA1B | |
| SCHEMBL12292867 | 0.73 | NNMT (0.49) | KLKB1ELANENNMTPLAUCACNA1B | |
| SCHEMBL7743802 | 0.73 | ITGB3 (0.56) | KLKB1NNMTPLAUCACNA1BITGB3 | |
| SCHEMBL13725054 | 0.73 | NNMT (0.50) | KLKB1ELANENNMTPLAUCACNA1B | |
| SCHEMBL13724150 | 0.73 | NNMT (0.50) | KLKB1ELANENNMTPLAUCACNA1B | |
| SCHEMBL29726666 | 0.72 | ITGB3 (0.54) | ITGB3ITGAVITGB5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025133350-A1 | COMPOSITIONS AND USES OF NON-CYCLIC PEPTIDES | ACTIVEN SA (CH) | 2025-06-26 | — | — | WO | disclosed |
| CN-117224709-A | Compositions and methods for inhibiting biofilm deposition and production | 宾夕法尼亚州立大学托管会 | 2023-12-15 | — | — | CN | disclosed |
| US-20230241186-A1 | COMPOSITIONS AND METHODS FOR INHIBITING BIOFILM DEPOSITION AND PRODUCTION | UNIV PENNSYLVANIA (US) | 2023-08-03 | — | — | US | disclosed |
| CN-109789191-B | Compositions and methods for inhibiting biofilm deposition and production | 宾夕法尼亚州立大学托管会 | 2023-08-01 | — | — | CN | disclosed |
| US-20220362381-A1 | REMOTELY TRIGGERED THERAPY | BAMBU VAULT LLC (US) | 2022-11-17 | — | — | US | disclosed |
| US-20220249627-A1 | COMPOSITIONS AND METHODS FOR INHIBITING BIOLFILM DEPOSITION AND PRODUCTION | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2022-08-11 | — | — | US | disclosed |
| US-11246819-B2 | Compositions and methods for inhibiting biofilm deposition and production | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2022-02-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11246819-B2 | Compositions and methods for inhibiting biofilm deposition and production | ADAM33, FGB, ADAM17 | KLKB1 913/4885ELANE 144/4885NNMT 1676/4885 |
| US-20220362381-A1 | REMOTELY TRIGGERED THERAPY | CD47, HSP90AA1, HSF1 | KLKB1 401/4885ELANE 1192/4885NNMT 3608/4885 |
| US-20230241186-A1 | COMPOSITIONS AND METHODS FOR INHIBITING BIOFILM DEPOSITION AND PRODUCTION | MMP1, MMP8, TIMP3 | KLKB1 1841/4885ELANE 47/4885NNMT 534/4885 |
| US-20220249627-A1 | COMPOSITIONS AND METHODS FOR INHIBITING BIOLFILM DEPOSITION AND PRODUCTION | ADAM33, CTRL, TIMP3 | KLKB1 671/4885ELANE 58/4885NNMT 1306/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.